Blood–Brain Barrier (BBB) Dysfunction in CNS Diseases: Paying Attention to Pericytes
Open Access
- 15 May 2025
- journal article
- review article
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 31 (5) , e70422
Abstract
Background: Dysfunction of the blood–brain barrier (BBB) is an important pathological mechanism in central nervous system (CNS) diseases and can trigger a series of pathological reactions, such as neuroinflammatory responses, oxidative stress, immune infiltration, etc., thereby worsening brain damage. However, pericytes are often overlooked by researchers, and no review research has yet summarized the mechanism by which pericytes contribute to BBB dysfunction in CNS diseases.Results: Therefore, this review explores the pathophysiology of BBB dysfunction in CNS diseases and provides a detailed account of the biological characteristics of pericytes, especially the controversy over their biomarkers. Subsequently, we review the role of pericytes in CNS diseases such as Alzheimer's disease, vascular dementia, multiple sclerosis, ischemic stroke, and hemorrhagic stroke, with a particular focus on the role of pericytes in BBB dysfunction. In addition, we also discuss treatments based on pericytes, such as regenerative medicine that induces pericyte differentiation and Pericyte‐Extracellular Vesicles.Conclusions: This review aims to provide a more comprehensive understanding and guidance on the role of pericytes in BBB dysfunction in CNS diseases and serve clinical treatment.Keywords
Funding Information
- National Natural Science Foundation of China (81960221, 82260249)
This publication has 188 references indexed in Scilit:
- Transcription Profiling of Platelet-Derived Growth Factor-B-Deficient Mouse Embryos Identifies RGS5 as a Novel Marker for Pericytes and Vascular Smooth Muscle CellsThe American Journal of Pathology, 2003
- NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesisDevelopmental Dynamics, 2001
- Clearance of Alzheimer’s amyloid-β1-40 peptide from brain by LDL receptor–related protein-1 at the blood-brain barrierJournal of Clinical Investigation, 2000
- Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo AngiogenesisScience, 1997
- CNS Microvascular Pericytes Express Macrophage-like Function, Cell Surface Integrin αM, and Macrophage Marker ED-2Microvascular Research, 1996
- The 140‐kDa Protein of Blood‐Brain Barrier‐Associated Pericytes Is Identical to Aminopeptidase NJournal of Neurochemistry, 1994
- Heterogeneity of microvascular pericytes for smooth muscle type alpha-actin.Journal of Cell Biology, 1991
- Blood-brain barrier in Alzheimer dementia and in non-demented elderlyActa Neuropathologica, 1987
- The pericyte—A reviewTissue and Cell, 1986
- Reactions of granular pericytes in a rabbit cerebrovascular ischemia model.Stroke, 1985